Advanced Diagnostics. Earlier Detection. Deeper Insights. Better Outcomes

The Cancer Diagnostics Stage will explore how genomic profiling, AI, and polygenic risk scores are transforming cancer diagnostics and screening as well as exploring the latest advances in liquid biopsy, ctDNA, and multi-modal approaches for early detection and MRD. 

Loading
11:30
  1. How Can Cancer Genomics Be Optimised To Maximise Patient Benefit Without Bankrupting The NHS?
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Michael Hubank
    Michael Hubank, Scientific Director of Clinical Genomics, The Royal Marsden NHS Foundation Trust
12:00
  1. Sponsored by n6. More details to be announced shortly.
    Cancer Diagnostics Stage
    30 mins
12:30
  1. Polygenic Risk Scores for Prostate Cancer Risk Stratification - Lessons From the BARCODE1 Study
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Rosalind Eeles
    Rosalind Eeles, Professor of Oncogenetics, The Institute of Cancer Research & Royal Marsden NHS Foundation Trust
13:00
  1. Lunch and Networking
    Cancer Diagnostics Stage
    90 mins
14:30
  1. MAVEs: Multiplex Assays of Functional Effect: Saying Goodbye To VUSs?
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Charlie Rowlands
    Charlie Rowlands, Research Bioinformatician, Institute of Cancer Research
15:00
  1. Sponsored by Sophia Genetics. More details to be announced shortly.
    Cancer Diagnostics Stage
    30 mins
15:30
  1. Exploiting Genome Evolution in Inflammatory Bowel Disease to Prevent Colorectal Cancer
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Trevor Graham
    Trevor Graham, Director of the Centre for Evolution and Cancer, The Institute of Cancer Research
16:00
  1. Networking Break
    Cancer Diagnostics Stage
    30 mins
16:30
  1. Making Liquid Biopsy Work for the NHS: The Potential of Long-Read Sequencing
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Andrew Beggs
    Andrew Beggs, Professor of Cancer Genetics & Surgery, University of Birmingham
17:00
  1. From One-Size-Fits-All to Personalised Cancer Screening
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Gareth Evans
    Gareth Evans, Emeritus Professor of Medical Genetics and Cancer Epidemiology, University of Manchester
17:30
  1. From Prognosis to Practice: How Should We Use ctDNA-Guided MRD Testing in Colorectal Cancer Today?
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Susanna Slater
    Susanna Slater, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust
11:30
  1. Integrating Circulating Tumour DNA into Treating Head and Neck Cance
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Ben O'Leary
    Ben O'Leary, Group Leader: Evolution and Translational Genomics, The Institute of Cancer Research
12:00
  1. Sponsored slot available
    Cancer Diagnostics Stage
    30 mins
12:30
  1. Developing a Clinically Useful Blood Test for Earlier Brain Tumour Diagnosis
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Paul Brennan
    Paul Brennan, Professor of Clinical and Experimental Neurosurgery, University of Edinburgh
13:00
  1. Lunch and Networking
    Cancer Diagnostics Stage
    70 mins
14:10
  1. Multimodal Liquid Biopsy for Early Cancer Detection: From Methylation to Single-Molecule Sequencing
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Anna Schuh
    Anna Schuh, Director of Molecular Diagnostics, University of Oxford
14:40
  1. MRD Through a Broader Genomic Lens: Findings from a retrospective study of NGS-based MRD analysis in AML sample cohorts
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Dave Bohanna
    Dave Bohanna, Business Development Manager, HCPC Registered Clinical Scientist, Oxford Gene Technology
15:10
  1. The Use of ctDNA as Biomarkers in Drug Development: Lessons From Early Phase Immunotherapy Clinical Trials
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Rodrigo Toledo
    Rodrigo Toledo, Group Leader, Biomarkers and Clonal Dynamics Group, VHIO
15:40
  1. Networking Break
    Cancer Diagnostics Stage
    30 mins
16:10
  1. Tracking Tumour and Host Response in Cancer Using Multi-Modal Liquid Biopsy
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Florent Mouliere
    Florent Mouliere, Group Leader, Cancer Research UK Manchester Institute
16:40
  1. Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA
    Cancer Diagnostics Stage
    30 mins
    Speaker(s)
    Speaker image for Alex Frankell
    Alex Frankell, Group Leader, University of Cambridge